Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOX18 | P35713 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | CTRC | Q99895 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | MC5R | P33032 | 1/20 | 0.35 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24293868 | 0.84 | L3MBTL1 (0.40) | TDP1L3MBTL1 | |
| SCHEMBL2863441 | 0.73 | L3MBTL1 (0.42) | TDP1L3MBTL1CYP1A2MAPK1 | |
| SCHEMBL24294058 | 0.70 | ACACB (0.34) | TDP1L3MBTL1CYP1A2 | |
| SCHEMBL14140930 | 0.70 | L3MBTL1 (0.39) | TDP1L3MBTL1CYP1A2MAPK1 | |
| SCHEMBL3092797 | 0.69 | GLA (0.47) | BACE1SIGMAR1CYP1A2CYP2A6HTR2A | |
| SCHEMBL4605184 | 0.69 | TDP1 (0.39) | TDP1L3MBTL1CYP1A2MAPK1 | |
| SCHEMBL6240981 | 0.67 | CYP1A2 (0.65) | SOX18SIGMAR1CYP1A2CYP2A6HTR2A | |
| SCHEMBL29560700 | 0.67 | CYP1A2 (0.65) | SOX18SIGMAR1CYP1A2CYP2A6HTR2A | |
| SCHEMBL932837 | 0.67 | MC5R (0.63) | SOX18SIGMAR1CYP1A2CYP2A6HTR2A | |
| SCHEMBL26745727 | 0.64 | SOX18 (0.63) | SOX18SIGMAR1CYP1A2CYP2A6HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230355557-A1 | ANTIVIRAL SOX INHIBITORS | GERTRUDE BIOMEDICAL PTY LTD (AU) | 2023-11-09 | — | — | US | disclosed |
| US-20230355557-A1 | ANTIVIRAL SOX INHIBITORS | GERTRUDE BIOMEDICAL PTY LTD (AU) | 2023-11-09 | — | — | US | disclosed |
| WO-2022040719-A1 | ANTIVIRAL SOX INHIBITORS | GERTRUDE BIOMEDICAL PTY LTD (AU) | 2022-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355557-A1 | ANTIVIRAL SOX INHIBITORS | SOX18, IRF3, YBX1 | SOX18 1/4885TDP1 411/4885L3MBTL1 918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.